Provisional Agenda
Wednesday 15th October 2008 Registration
Day 1 - Thursday 16th October 2008
09:00-12:00 Session I: Embryonic stem cells
Chair: Robert Lanza
09:00-9:45 Embryonic Stem Cells- Moving from the Laboratory to the Clinic
Robert Lanza, Chief Scientific Officer, Advanced Cell Technologies, USA
09:45-10:15 NANOG is a Direct Target of TGFb/Activin Mediated SMAD Signaling in Human ES Cells
Renhe Xu, Associate Professor, University of Connecticut Health Center, USA
10:15-10:45 Generation of pancreatic islet cells from embryonic stem cells
Deng Hongkui, Professor, Beijing University, China
10:45-11:00 Coffee Break
11:00-11:30 The effect of endothelial cells on cardiomyocyte differentiation
Zack Wang, Principal Investigator, Maine Medical Center Research Center, USA
11:30-12:00 Biological properties of hemangioblasts derived from human embryonic stem cells
Shijiang Lu, Senior Scientist, Advanced Cell Technologies, USA
12:00-14:00 Lunch and Poster Presentations
14:00 pm-17:30 pm Session II: Somatic stem cells
Chair: Linheng Li
14:00-14:30 Stem cell Niche and cancer stem cells
Linheng Li, Investigator, Stowers Institute for Medical Research, USA
14:30-15:00 Pericytes as a new stem cell source
Bruno Peault, Professor, University of Pittsburgh, USA
15:00-15:30 Title to be confirmed
Zhongchao Han, Institute of Hematology, CAMS
15:30-16:00 Cell cycle control of physiological stem cells
Tao Cheng, Associate Professor, University of Pittsburgh, USA
16:00-16:15 Coffee Break
16:15-16:45 Inactivation of Proapoptotic PUMA Selectively Protects Hematopoietic Stem and Progenitor Cells from Lethal Dose gamma-Irradiation
Wenshu Wu, Assistant Professor, Maine Medical Center Research Center, USA
16:45-17:15 Human/goat and human/mouse xenograft chimerism to investigate stem cell characteristics and functions through in utero transplantation
Fanyi Zeng, Professor, Institute of Medical Genetics, Shanghai Jiaotong University
17:15-17:45 Title to be confirmed
Xuetao Pei, Professor, Beijing Institute for Transfusion Medicine, USA
17:45 Dinner: Open discussion on potential international collaborations and advantages of doing stem cell research/business in China
Day 2 - Friday 17th October 2008
08:30-09:15 Keynote Presentation
Introduction for the Keynote speaker
Jerry Yang, Professor, University of Connecticut Health Center, USA
Keynote Address: Title to be confirmed
Ian Wilmut, Professor, University of Edinburgh, UK
09:15-09:30 Coffee Break
09:30-12:15 Session III: Reprogramming
Chair: Duanqing Pei
09:30-10:00 Reprogramming of differentiated somatic cells by Nuclear Transplantation
Shaorong Gao, Investigator, National Institute of Biological Sciences, China
10:00-10:30 Epigenetic reprogramming in the establishment of new pluripotent parthenogenetic embryonic stem cells
Lin Liu, Professor, Nankai University, Tianjin, China
10:30-11:00 iPS mediated reprogramming of adult cells
Duanqing Pei, Professor, Chinese Academy of Science-Guangzhou Branch, China
11:00-11:30 Epigenetic regulation of gene expression in pluripotent stem cells
Fan Guoping, Associate Professor, University of California Los Angeles, USA
11:30-12:00 Molecular regulation of pluripotency in embryonic stem cells
Ying Jin, Professor, Institute of Health Science, SIBS, CAS, Shanghai, China
12:00-14:00 Lunch and Poster Presentations
14:00-17:30 Session IV: Stem cell manipulations and Pathogenic stem cells
Chair: Lingzhao Cheng
14:00-14:30 Human pluripotent stem cells: A useful model for human biology and disease?
Lingzhao Cheng, Associate Professor, Johns Hopkins University, USA
14:30-15:00 Title to be confirmed
Linsong Li, Professor, Beijing University, China
15:00-15:30 SHP-2 tyrosine phosphatase in hematopoietic stem cell disorder
Chengkui Qu, Associate Professor, Case Western Reserve University, USA
15:30-15:45 Coffee Break
15:45-16:15 Conversion of spermatogonial stem cells into oocytes in vitro
Lixin Feng, Professor, Shanghai Jiaotong University, China
16:15-16:45 Signaling regulation of asymmetric cell division
Huashun Li, Professor, Shichuan University, China
16:45-17:15 Title to be confirmed
Mahendra Rao, Vice President of Research, Invitrogen, USA
18:00 Dinner: Open discussion on potential international collaborations and advantages of doing stem cell research/business in China
Day 3 - Saturday 18th October 2008
08:30-12:00 Session V: Stem cell application and tissue engineering
Chair: Yilin Cao
08:30-09:00 Title to be confirmed
Yilin Cao, Professor, National Tissue Engineering Research and Development Center, Shanghai Jiaotong University, China
09:00-09:30 Title to be confrmed
Jianhong Zhu, Fudan University, Haushan Hospital, Shanghai, China
09:30-10:00 Studies on Flk1+CD21-CD34- stem cells and its implications in the regenerative medicine
Robert Zhao, Professor, Institute of Basic Medical Sciences, CAMS, China
10:00-10:15 Coffee Break
10:15-10:45 A chemical approach to stem cell biology
Sheng Ding, Associate Professor, The Scripps Research, USA
10:45-11:15 Market Opportunities for Stem Cells in Regenerative Medicine-An Industry Analysis
Enal Razvi, Biotechnology Analyst, Select Biosciences, UK
11:15-11:45 Title to be confirmed
Lugui Qiu, Professor, Institute of Hematology, CAMS, China
11:45-13:30 Lunch and Poster Presentations
13:30-14:15 Keynote Presentation:
Role of transcription factors in hematopoietic stem cell self-renewal and aging
Daniel Tenen, Professor, Harvard University, USA and National University, Singapore
Session VI: Hematopoietic stem cells and leukemic stem cells
Chair: Yong-Guang Yang
14:15-14:45 Therapeutic Targeting of t(8;21) Leukemia Stem Cells
Dong-Er Zhang, professor, University of California San Diego, USA
14:45-15:15 Quiescent hematopoietic stem cells are highly deficient in repair of DNA double strand breaks
Daohong Zhou, Professor, Medical University of South Carolina, USA
15:15-15:45 Survival mechanisms of leukemic stem cells
Shaoguang Li, Associate Professor, University of Massachusetts Medical School, USA
15:45-16:00 Coffee Break
16:00-16:30 Induction of Transplantation Tolerance using Hematopoietic Stem cells
Yong-Guang Yang, Associate Professor, Harvard University and Massachusetts General Hospital, USA
16:30-17:00 The Role of STAT5 Activation in Hematopoietic Stem Cell Transplantation
Kevin Buntin, Associate Professor, Case Western Reserve University, USA
17:00-17:30
17:30 Close of Conference